Pacemakers Market Size, Share, and Trends 2024 to 2034

Pacemakers Market (By Product: Internal pacemakers, External pacemakers; By Type: MRI Compatible, Conventional, Customary; By Implantability: Implantable Pacemaker, Hospital & Cardiac Centers, Ambulatory Surgical Centers, External Pacemaker; By Application: Arrhythmias, Congestive Heart Failure, Others; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032

  • Last Updated : January 2024
  • Report Code : 1818
  • Category : Healthcare

Pacemakers Market Size and Companies

The global pacemakers market size was accounted at USD 5.55 billion in 2022 and it is projected to surpass around USD 9.44 billion by 2032 with a registered CAGR of 5.50% during the forecast period 2023 to 2032.

Pacemakers Market Size 2023 to 2032

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America led the global market with the highest market share of 44% in 2022.
  • By Product, the internal pacemakers segment has held the largest market share of 62% in 2022.
  • By Type, the Conventional Pacemakers segment captured the biggest revenue share of 53% in 2022.
  • By Implantability, the implantable segment is estimated to hold the highest market share in 2022.
  • By Application, the Arrhythmias segment registered the maximum market share of 39% in 2022.
  • By End-use, the hospital & cardiac centers segment generated over 62% of revenue share in 2022.

Pacemakers Market in the U.S. 2023 To 2032

The U.S. pacemakers market size was valued at USD 1.80 billion in 2023 and is expected to reach USD 2.93 billion by 2032, growing at a CAGR of 5.60% from 2023 to 2032.

U.S. Pacemakers Market Size 2023 to 2032

North America ruled the market for pacemakers and represented the biggest income portion of around 44% in 2022. This development is inferable from the rising old populace with heart issues, the presence of central participants, fast mechanical headways, for example, MRI viable pacemakers, Bluetooth empowered pacemakers, and working on administrative endorsements. The rate of cardiovascular problems, like heart failures, congestive cardiovascular breakdown, and arrhythmias is expanding quickly in the U.S., which is further driving the interest for pacemakers in the district. Additionally, mechanical progressions in the medical services area and the rising number of heart-related medical procedures are driving the market in the locale.

In Asia Pacific, the market is probably going to show a rewarding CAGR of around 4.9% over the assessed period. This development of the market in the locale is attributable to advertise entrance by the vital participants, and monstrous undiscovered open doors are driving the development. Besides, interests in the medical care area, particularly in Japan, China, and India have gotten momentum. These nations are continuously centered on creating lively medical services offices for cardiovascular determination and therapy. Such factors are expected to drive market development before very long. Developing economies and populaces in agricultural nations including China and India are supposed to set out significant open doors for the market in the district.

Pacemakers Market Share, By Region, 2022 (%)

Growth Factors

Pacemaker is characterized as the clinical gadget, which sends little driving forces to heart muscles to keep up with reasonable pulse or to animate the lower offices of the hearts. It is utilized for the treatment of syncope, congestive cardiovascular breakdown, and hypertrophic cardiomyopathy. The development of the worldwide pacemaker market is significantly determined by expansion popular for negligible obtrusive method, ascend in financing from private and government associations for the medical services area, and ascend in pervasiveness of cardiovascular sicknesses. As per Drugs and Diseases, in April 2020, it was accounted for that super durable pacemaker addition strategy is considered as the negligibly obtrusive method. In this way, ascend sought after for negligibly obtrusive surgery and expansion in reception of heart surgery, for example, endocardial or epicardial for the implantation of pacemaker drive the development of the worldwide market. For example, in 2020, Abbott Laboratories, an American worldwide clinical gadget and medical organization, has spent across $2.42 billion in the R&D area. As per the World Health Organization (WHO), in 2019, it was accounted for that 17 million people younger than 70 kicked the bucket because of respiratory failure.

 The rise in geriatric populace is supposed to fuel the market development during the estimate time frame. This is ascribed to the way that matured people are profoundly helpless against cardiovascular illnesses. Besides, improvements in pacemaker move the development of the market. For example, in January 2020, Medtronic Plc., a clinical gadget organization, reported the endorsement of Micra AV, which is the littlest pacemaker with atrioventricular (AV) synchrony. The micra AV is utilized for the treatment of patient experience the ill effects of AV block. Moreover, a scientist at Northwestern and George Washington Universities, in 2020, in the U.S., declared the send off of first transient pacemaker, which get disintegrated in the body after its utilization. The pacemaker is remote, sans battery, and totally implantable pacing gadget, which offers brief pacing without the need of ambulatory extraction. In this manner, the presence of vital participants in medical services clinical gadgets, good unofficial law for improvement of cutting edge pacemaker, and ascend in frequency of hypertension move the development of the market.

Rising occurrences of CVDs, inflating cost of cardiovascular illness the executives, ideal government approaches, and the send off of mechanically progressed pacemakers, for example, the MRI safe pacemakers and leadless pacemakers are mainly driving the development on the lookout. The rising weight of cardiovascular sicknesses is one of the vital variables for the development of the market. Coronary heart problem is one of the essential purposes behind CVD passings universally. The monetary weight of these sicknesses is expected to be more than USD 1,044 billion by 2032, which features the incredible requirement for heart pacing gadgets.

The novel Covid had seriously impacted patients experiencing cardiovascular illness. The spread of COVID-19 financially affected the medical services and clinical gadget industry. According to the American Heart Association, Circulation Journal, 2020, up to this point COVID-19 had impacted 185 nations and in excess of 30,00,000 patients worldwide. Among patients with COVID-19, there is a high commonness of CVD. Expanding request to work on understanding results for different pacemaker implantations, with improved and negligibly obtrusive systems is the key component driving the development of the pacemaker market. In addition, good repayment methods, like the Medicare framework in the U.S. also, NHS in the U.K. are among the key variables helping the market.

Clinical gadget organizations, for example, Boston Scientific Corporation and Medtronic are currently offering new products that are covered under repayment bundles, which benefit patients. Besides, associations are more focused on assembling very good quality pacemakers taking special care of redone care. These advancements are improving exactness, giving extra abilities to upgrade the work process, and working with mistake decrease. This is a critical move for routine remote subsequent meet-ups in the midst of COVID-19. 

Report Scope of the Pacemakers Market

Report Coverage Details
Market Size by 2032 USD 9.44 Billion
Growth Rate from 2023 to 2032

CAGR of 5.50%

North America Market Share in 2022 44%
Conventional Pacemakers Market Share in 2022 53%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Product, Type, Implantability, Application, End-use, Geography
Companies Mentioned Boston Scientific Corporation, Zoll Medical Corporation, Medtronic, BIOTRONIK, MicroPort Scientific Corporation, Cook Medical, MEDICO SpA, Pacetronix, Oscor Inc., Osypka Medical GmbH, St. Jude Medical Inc., LivaNova PLC.,, Osypka Medical GmbH, MEDICOWEB, Others


Products Insights

The internal pacemakers section held the biggest portion of over 62% of the pacemakers' market in 2022. The developing interest for these gadgets for the treatment of cardiovascular breakdown and arrhythmias as well as progressing clinical preliminaries is a main consideration prompting market development. In 2017 atrial fibrillation was the most widely recognized type of arrhythmia, influencing roughly 2.7 to 6.1 million individuals in the U.S alone according to the CDC. In this way, the market development is driven by a rising predominance of CVDs.

The dual chamber pacemaker fragment ruled the market in 2022, and is supposed to proceed with this pattern during the figure time frame, attributable to increment in commonness of bradycardia, presence of vital participants, and ascend in geriatric populace. In any case, the biventricular section is supposed to observe extensive market development during the conjecture time frame, attributable to increment sought after for remote checking administrations, ascend in pervasiveness of hypertension, and flood in number of cell phone clients.

Pacemakers Market Share, By Product, 2021 (%)

The external pacemaker section is supposed to show promising development during the gauge time frame because of the simple design, upgraded UI, and further developed low battery marker. Since outside pacemakers are painless, there is less gamble of postsurgical inconveniences. Furthermore, the gadgets are helpful for patients to track and record day to day heart capabilities. Moreover, outside pacemakers are the quickest accessible gadgets for synchronization of cardiovascular beat, as most would consider to be normal to fuel portion development. The presence of market players like Medtronic, Pacetronix, and Oscor Inc., managing in the external pacemakers' is additionally expected to impact portion development emphatically.

Type Insights

As far as income, the conventional pacemakers fragment ruled the market and represented the biggest income portion of more than 53% in 2022. This development is attributable to consistent upgradations, reasonableness, little estimated, and prolonged timeframe of realistic usability. 

The market is sectioned into MRI compatible and customary pacemakers. The MRI compatible pacemaker fragment is supposed to show rewarding development during the gauge time frame. The high offer is inferable from expanded MRI-based finding. According to the Mayo Foundation for Medical Education and Research, 2018, roughly 75% of patients who are as of now having an implantable pacemaker will require MRI during their lifetimes. Thus, the section is seeing high development.

Implantability Insights

Based on implantability, the implantable pacemaker portion ruled the market in 2022, and is supposed to proceed with this pattern during the estimate time frame, attributable to increment in occurrence of bradycardia, ascend sought after for implantable pacemaker, and headway in R&D exercises in the medical care area. In any case, the outside pacemaker portion is supposed to observe extensive development during the conjecture time frame, attributable to increment in pervasiveness of coronary illness, ascend in the geriatric populace, and advancement of innovation in the medical services industry.

Application Insights

The arrhythmias portion overwhelmed the pacemakers’ market and held the biggest income portion of 39% in 2022. The fragment is additionally partitioned into atrial fibrillation, heart block, and long QT condition. Factors, for example, way of life issues, unnecessary liquor utilization, smoking, and weight are adding to the predominance of cardiovascular arrhythmia. According to the European Medical Group LTD, 2019, the absolute commonness of individuals with atrial fibrillation and atrial vacillate is 12,32,145 in the U.K. The congestive cardiovascular breakdown portion is the second-quickest developing fragment during the estimate time frame. According to the CDC, in December 2019, almost 6.5 million grown-ups in the U.S. experience the ill effects of cardiovascular breakdown. Accordingly, expanding the frequency of cardiovascular breakdown has filled the interest for innovatively progressed pacemakers during the estimate time frame.

End-use Insights

The hospitals and cardiac centers held a prevailing portion of around 62% in 2022. Emergency clinics and cardiovascular focuses offer better consideration than their patients while they are conceded. Furthermore, these focuses additionally offer repayments during medical procedures, consequently, driving the development of the portion. The American heart affiliation expressed that the quantity of in-patients because of heart failure is supposed to rise almost by 24 million by 2032. The end-use fragment is separated into emergency clinics and cardiovascular focuses, mobile ambulatory focuses, and others.

The ambulatory surgical centers portion is supposed to show promising development during the gauge time frame inferable from its high-level market reach particularly to country parts and simplicity of treatment. The ambulatory surgical centers have demonstrated to be an equipped arrangement in this situation. Furthermore, the developing interest to check the ambulatory and post-ambulatory costs and the developing predominance of CVDs are expected to be a couple of the great effect delivering drivers for the ambulatory surgical centers fragment. In addition, decreasing medical services costs and further developing patient experience are different variables driving the section.

Key Market Developments

  • In June 2021, Medtronic sent off the Micra AV, an independent, scaled down pacemaker for conveying progressed pacing innovation for atrioventricular (AV) block patients through a negligibly obtrusive methodology.
  • in May 2020, the home checking framework by BIOTRONIK offered a financially savvy and safe distant administration of pacemaker patients at the Large Multi-Center Study.
  • In November 2017, Medtronic got FDA endorsement and sent off the Azure pacemaker with BlueSync innovation in the US market
  • In March 2016, St. Jude Medical got the CE Mark accreditation for MRI similarity for its Nanostim leadless pacemakers.
  • The key market players are constantly engaged in various developmental strategies like partnership, collaborations, new product launches, and acquisitions to strengthen their market position and gain market share.

Some of the prominent players:

  • Boston Scientific Corporation
  • Zoll Medical Corporation
  • Medtronic
  • MicroPort Scientific Corporation
  • Cook Medical
  • Pacetronix
  • Oscor Inc.
  • Osypka Medical GmbH
  • St. Jude Medical Inc.
  • LivaNova PLC.
  • Osypka Medical GmbH
  • Others

Segments Covered in the Report

By Product

  • Internal pacemakers
    • Single Chamber
    • Dual Chamber
    • Biventricular Chamber
  • External pacemakers

By Type

  • MRI Compatible Pacemakers
  • Conventional Pacemakers
  • Customary Pacemakers

By Implantability

  • Implantable Pacemaker
  • Hospital & Cardiac Centers
  • Ambulatory Surgical Centers

By Application

  • Arrhythmias
    • Atrial Fibrillation
    • Heart Block
    • Long QT Syndrome
  • Congestive Heart Failure
  • Others

By End-use

  • Hospitals & Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

The global pacemakers market size was reached at USD 5.55 billion in 2022 and it is anticipated to rake around USD 9.44 billion by 2032.

The global pacemakers market growth is expanding at a CAGR of 5.50% over the next ten years.

The major players operating in the pacemakers market are Boston Scientific Corporation, Zoll Medical Corporation, Medtronic, BIOTRONIK, MicroPort Scientific Corporation, Cook Medical, MEDICO SpA, Pacetronix, Oscor Inc., Osypka Medical GmbH, St. Jude Medical Inc., LivaNova PLC.,, Osypka Medical GmbH, MEDICOWEB, Others.

The rise in geriatric populace and rising occurrences of CVDs are supposed to fuel the market development during the estimate time frame.

North America region will lead the global pacemakers market over the next ten years.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client